Virtus Biotech ETF
BBP
15 hedge funds and large institutions have $8.16M invested in Virtus Biotech ETF in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
39% more capital invested
Capital invested by funds: $5.89M → $8.16M (+$2.27M)
15% more funds holding
Funds holding: 13 → 15 (+2)
6.3% more ownership
Funds ownership: 28.7% → 35% (+6.3%)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.61M |
| 2 |
Jane Street
New York
|
+$1.05M |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$418K |
| 4 |
Morgan Stanley
New York
|
+$348K |
| 5 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$287K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$459K |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
-$416K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$287K |
| 4 |
JCM
Jag Capital Management
St Louis,
Missouri
|
-$212K |
| 5 |
CAMG
CWA Asset Management Group
Naples,
Florida
|
-$102K |
BBP Hedge Fund Activity: Q2 2025 in Review
15 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q2 2025, worth a combined $8.16M — up 39% from $5.89M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BBP positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.61M. The largest seller was Royal Bank of Canada, cutting an estimated $459K.
- 15 institutional investors held Virtus Biotech ETF (BBP) as of Q2 2025, up from 13 in Q1 2025.
- Funds reported $8.16M of Virtus Biotech ETF stock for Q2 2025, up 39% quarter-over-quarter.
- 5 funds opened new Virtus Biotech ETF positions in Q2 2025 and 3 closed out, a net change of +2 holders.
- The largest Virtus Biotech ETF buyer in Q2 2025 was Susquehanna International Group, an estimated $1.61M added.
- The largest Virtus Biotech ETF seller in Q2 2025 was Royal Bank of Canada, an estimated $459K sold.
Based on aggregated 13F filings for Q2 2025.